Trump’s vaccine ‘October surprise’ in doubt as FDA toughens standards
Sorrento Spikes 11% On Positive RTX Epidural Data In Cancer Patients
U.S. health agency sets October 16 deadline for states to submit vaccine plans
How and when will we know that a COVID-19 vaccine is safe and effective?
Political interference fears mount as Trump backs Pfizer’s COVID vaccine
CRISPR-based malaria testing on-the-fly
Explainer: How clinical trials test COVID-19 vaccines
Silicon Valley startup Visby’s portable Covid-19 test gets FDA approval
Biden Joins FDA Critics, Seeks Independent Vaccine Review
Lilly, Amgen partner to manufacture potential Covid-19 drugs
Sorrento Pops 28% On FDA Nod To Kick Off Covid-19 Antibody Trial
Concerns Mount – FDA May Approve Deadly Vaccine
Abbott Starts Shipping 15-Minute Covid-19 Test After FDA Emergency Use Nod
Covid-19 Vaccine Makers’ Pledge May Not Quell Uprising
Aiming for accuracy
Eli Lilly’s rheumatoid arthritis drug accelerates recovery in Covid-19 patients
Big pharma's safety pledge isn't enough to build public confidence in COVID-19 vaccine – here's what will
Exclusive: U.S. hospitals turn down remdesivir, limit use to sickest Covid-19 patients
Covid-19 roundup: NIH spotlights blood thinners in its next big trial; All it took was a pandemic to get JPM out of SF
Moderna Stock Could Tumble Over 20%, Says Analyst
Kamada Rises 5% On Initial Phase 1/2 Trial Results For Covid Treatment
COVID19 vaccine makers’ pledge no better than NRA’s promises
England trials population testing for COVID-19
How to Stymie Distribution of a Potentially Dangerous Vaccine
Innovative biocontainment unit shows promise to protect healthcare workers
Abbot Labs: New COVID-19 Antibody Test Is a Game Changer, Says Analyst
A ‘Human’ Touch vs. COVID-19
New COVID-19 “Papers” Could Determine Who Can and Cannot Enter Buildings
Oppenheimer: These 3 Penny Stocks Have Triple-Digit Upside Potential
Medical Groups Can Fight Possibly Deadly COVID-19 Vaccine